Diphenylhydantoin is not genotoxic in a battery of short‐term cytogenetic assays
作者:
D. Kindig,
M. L. Garriott,
J. W. Parton,
J. D. Brunny,
J. E. Beyers,
期刊:
Teratogenesis, Carcinogenesis, and Mutagenesis
(WILEY Available online 1992)
卷期:
Volume 12,
issue 1
页码: 43-50
ISSN:0270-3211
年代: 1992
DOI:10.1002/tcm.1770120106
出版商: Wiley Subscription Services, Inc., A Wiley Company
关键词: anticonvulsant;phenytoin;genotoxicity;chromosome aberration;micronucleus;sister chromatid exchange;transplacental
数据来源: WILEY
摘要:
Abstract5,5‐Diphenylhydantoin (DPH) is an antiepileptic drug associated with an increase in malformations in infants born to women taking DPH during pregnancy. Positive and negative results have been reported by various investigators for in vivo and in vitro chromosome aberration (CAB) assays, in vivo and in vitro sister chromatid exchange (SCE) assays, and in vivo micronucleus tests (MNT). In this laboratory, DPH was tested in an in vitro CAB assay using Chinese hamster ovary cells with and wihout an S‐9 activation system, an in vivo SCE assay in female CD‐1 mice, an in vivo MNT, using both male and female CD‐1 mice, and a transplacental micronucleus test. The results from this comprehensive battery of cytogenetic tests were uniformly negative and support a conclusion that the known teratogen, DPH, is not clastogenic. © 1992 Wiley
点击下载:
PDF
(448KB)
返 回